<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04931251</url>
  </required_header>
  <id_info>
    <org_study_id>LCCC1941</org_study_id>
    <secondary_id>R01CA240092</secondary_id>
    <nct_id>NCT04931251</nct_id>
  </id_info>
  <brief_title>Addressing Cancer-Related Financial Toxicity in Rural Oncology Care Settings</brief_title>
  <official_title>Addressing Cancer-Related Financial Toxicity in Rural Oncology Care Settings</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>UNC Lineberger Comprehensive Cancer Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>National Cancer Institute (NCI)</agency>
      <agency_class>NIH</agency_class>
    </collaborator>
  </sponsors>
  <source>UNC Lineberger Comprehensive Cancer Center</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The financial burden, or financial toxicity (FT), of cancer is a consequential and growing&#xD;
      problem, particularly for rural patients. It is important to improve our understanding of how&#xD;
      financial navigation (FN) can reduce the material, psychological, and behavioral burden of&#xD;
      costs associated with cancer care in both rural and non-rural community settings. The purpose&#xD;
      of this study is to conduct a financial navigation program in 5 rural and 4 non-rural&#xD;
      oncology practices in North Carolina and evaluate the effects of financial navigation on&#xD;
      patient outcomes, including financial toxicity and health-related quality of life.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This study is designed to evaluate the implementation and effectiveness of a financial&#xD;
      navigation intervention within 5 rural and 4 non-rural oncology settings in North Carolina.&#xD;
      Financial navigators from each of the 9 sites will recruit and enroll 780 patients total&#xD;
      across all sites into a financial navigation program. The financial navigation intervention&#xD;
      consists of screening patients using the COST measure for financial toxicity. If the patient&#xD;
      scores 23 or lower, they are considered to have moderate to severe financial toxicity and&#xD;
      will be enrolled in the study. Patients will then complete a series of baseline&#xD;
      questionnaires to measure their health related quality of life and then they will meet with a&#xD;
      financial navigator for a comprehensive intake process to determine potential financial&#xD;
      assistance resources the patient may be eligible for and continued visits with the financial&#xD;
      navigator until all financial assistance resources have been explored and patients have&#xD;
      received benefits or referrals to financial assistance programs. At the end of the&#xD;
      intervention, the patients will complete the COST measure again, and repeat baseline surveys&#xD;
      to measure health-related quality of life and the patient's acceptability and responsiveness&#xD;
      of the financial navigation intervention. Patient participation depends on the depth of&#xD;
      patient need but ranges from 2 visits to 6 visits with the financial navigator over&#xD;
      approximately 4 months but possibly longer depending on the complexity of the patient's&#xD;
      financial need.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">November 1, 2021</start_date>
  <completion_date type="Anticipated">July 31, 2023</completion_date>
  <primary_completion_date type="Anticipated">January 31, 2023</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <intervention_model_description>This is a multi-site, single arm, financial navigation intervention</intervention_model_description>
    <primary_purpose>Health Services Research</primary_purpose>
    <masking>None (Open Label)</masking>
    <masking_description>no masking</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>COST (Comprehensive Score for Financial Toxicity) measure</measure>
    <time_frame>4-6 months</time_frame>
    <description>To evaluate the change from baseline to follow-up in scores from the Comprehensive Score for Financial Toxicity (COST) measure after participation in the financial navigation program among 780 rural and non-rural NC cancer patients with high baseline financial distress.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Health-Related Quality of Life (HrQoL) Measures</measure>
    <time_frame>4-6 months</time_frame>
    <description>To evaluate the change from baseline to follow-up in scores from HRQoL, care-altering behaviors and patient perspectives on the intervention itself</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">780</enrollment>
  <condition>Neoplasms</condition>
  <condition>Carcinoma</condition>
  <arm_group>
    <arm_group_label>Financial Navigation</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>includes a financial toxicity screening measure (COST), baseline and post-intervention surveys, and approximately 2-6 visits with a financial navigator to identify financial assistance resources</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Financial Navigation</intervention_name>
    <description>providing financial navigation for cancer patients in NC to identify available financial assistance resources to assist patients with the cost of cancer</description>
    <arm_group_label>Financial Navigation</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Patients 18 years of age and older&#xD;
&#xD;
          -  Patients with any type of cancer diagnosed within 5 years and/or living with advanced&#xD;
             disease&#xD;
&#xD;
          -  Patients who score 22 or lower on the COST measure indicating high FT&#xD;
&#xD;
          -  Patients must be able to read and speak English&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Participants without a cancer diagnosis&#xD;
&#xD;
          -  Patients diagnosed more than 5 years ago without advanced disease&#xD;
&#xD;
          -  Patients or caregivers under the age of 18&#xD;
&#xD;
          -  Patients who do not sign the consent form&#xD;
&#xD;
          -  Patients who do not complete the baseline COST survey&#xD;
&#xD;
          -  Patients who cannot read and speak English&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Stephanie Wheeler, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Michelle L Manning, MPH</last_name>
    <phone>919-843-8506</phone>
    <email>mlmannin@email.unc.edu</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Mindy Gellin, RN</last_name>
    <phone>919-966-9519</phone>
    <email>mindy_gellin@med.unc.edu</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Novant Health</name>
      <address>
        <city>Charlotte</city>
        <state>North Carolina</state>
        <zip>28207</zip>
        <country>United States</country>
      </address>
    </facility>
    <contact>
      <last_name>Principal Investigator</last_name>
      <phone>704-384-3119</phone>
      <email>thyoung@novanthealth.org</email>
    </contact>
    <contact_backup>
      <last_name>Social Worker</last_name>
      <phone>704-384-9497</phone>
      <email>deborah.johnson@novanthealth.org</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Vidant Medical Center, Cancer Center</name>
      <address>
        <city>Greenville</city>
        <state>North Carolina</state>
        <zip>27834</zip>
        <country>United States</country>
      </address>
    </facility>
    <contact>
      <last_name>Principal Investigator</last_name>
      <phone>252-816-2744</phone>
      <email>phyllis.deantonio@vidanthealth.com</email>
    </contact>
    <contact_backup>
      <last_name>Social Worker</last_name>
      <phone>2527179681</phone>
      <email>ashley.williams@vidanthealth.com</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Pardee UNC Health Care, Pardee Cancer Center</name>
      <address>
        <city>Hendersonville</city>
        <state>North Carolina</state>
        <zip>28739</zip>
        <country>United States</country>
      </address>
    </facility>
    <contact>
      <last_name>Principal Investigator</last_name>
      <phone>828-692-8045</phone>
      <email>devan.spear@unchealth.unc.edu</email>
    </contact>
    <contact_backup>
      <last_name>Financial Navigator</last_name>
      <phone>(828)694-8028</phone>
      <email>amber.minugh@unchealth.unc.edu</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>UNC Lenoir Cancer Care Services</name>
      <address>
        <city>Kinston</city>
        <state>North Carolina</state>
        <zip>28501</zip>
        <country>United States</country>
      </address>
    </facility>
    <contact>
      <last_name>Principal Investigator</last_name>
      <phone>252-522-7077</phone>
      <email>dvestal@lenoir.org</email>
    </contact>
    <contact_backup>
      <last_name>Social Worker</last_name>
      <phone>252-522-7600</phone>
      <email>mevans@lenoir.org</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Carteret Health Care Cancer Center</name>
      <address>
        <city>Morehead City</city>
        <state>North Carolina</state>
        <zip>28557</zip>
        <country>United States</country>
      </address>
    </facility>
    <contact>
      <last_name>Principal Investigator</last_name>
      <phone>252-499-6630</phone>
      <email>sking@carterethealth.org</email>
    </contact>
    <contact_backup>
      <last_name>Social Worker</last_name>
      <phone>252-499-6621</phone>
      <email>lsilvano@carterethealth.org</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>The Outer Banks Hospital</name>
      <address>
        <city>Nags Head</city>
        <state>North Carolina</state>
        <zip>27959</zip>
        <country>United States</country>
      </address>
    </facility>
    <contact>
      <last_name>Financial Navigator</last_name>
      <phone>252-449-5798</phone>
      <email>Stacy.Marshall@theobh.com</email>
    </contact>
    <contact_backup>
      <last_name>Social Worker</last_name>
      <phone>252-449-2314</phone>
      <email>Janet.Creef@theobh.com</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>CarolinaEast Health System</name>
      <address>
        <city>New Bern</city>
        <state>North Carolina</state>
        <zip>28560</zip>
        <country>United States</country>
      </address>
    </facility>
    <contact>
      <last_name>Principal Investigator</last_name>
      <phone>252-636-5135</phone>
      <email>SCarroll@carolinaeasthealth.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Nash UNC Health Care</name>
      <address>
        <city>Rocky Mount</city>
        <state>North Carolina</state>
        <zip>27804</zip>
        <country>United States</country>
      </address>
    </facility>
    <contact>
      <last_name>Principal Investigator</last_name>
      <phone>252-962-6707</phone>
      <email>sterling.grimes@unchealth.unc.edu</email>
    </contact>
    <contact_backup>
      <last_name>Financial Navigator</last_name>
      <phone>252-962-8107</phone>
      <email>Sheila.Chesnut@unchealth.unc.edu</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Wake Forest University Health Sciences</name>
      <address>
        <city>Winston-Salem</city>
        <state>North Carolina</state>
        <zip>27157</zip>
        <country>United States</country>
      </address>
    </facility>
    <contact>
      <last_name>Principal Investigator</last_name>
      <phone>919-357-2662</phone>
      <email>sbirken@wakehealth.edu</email>
    </contact>
    <contact_backup>
      <last_name>Financial Navigator</last_name>
      <phone>(336) 713-2688</phone>
      <email>pledfor@wakehealth.edu</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <link>
    <url>http://unclineberger.org/patientcare/clinical-trials/clinical-trials</url>
    <description>UNC Lineberger Comprehensive Cancer Center Clinical Trials</description>
  </link>
  <verification_date>October 2021</verification_date>
  <study_first_submitted>June 11, 2021</study_first_submitted>
  <study_first_submitted_qc>June 11, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">June 18, 2021</study_first_posted>
  <last_update_submitted>October 28, 2021</last_update_submitted>
  <last_update_submitted_qc>October 28, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">October 29, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Financial Toxicity</keyword>
  <keyword>Cancer</keyword>
  <keyword>Financial Navigation</keyword>
  <keyword>Carcinoma</keyword>
  <keyword>Neoplasms</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Neoplasms</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
    <ipd_description>We commit to broadly sharing appropriate materials and de-identified data that are developed with support from the NIH, while protecting participant privacy and confidentiality in accordance with best human subjects research practices and Health Insurance Portability and Accountability Act (HIPAA) guidelines. We commit to the collection, cataloging, protecting, and sharing of clinical and other research data and resources that is consistent with NIH policies, using the Research Electronic Data Capture (REDCap) platform as the mechanism for data storage, protection and sharing. We will only share de-identified IPD.</ipd_description>
    <ipd_info_type>Study Protocol</ipd_info_type>
    <ipd_time_frame>The de-identified data will become available after study completion.</ipd_time_frame>
    <ipd_access_criteria>The access criteria for accessing our de-identified participant data is still being developed.</ipd_access_criteria>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

